Anthem, Inc. (ANTM)
(Delayed Data from NYSE)
$261.70 USD
+0.11 (0.04%)
Updated May 3, 2019 04:00 PM ET
After-Market: $261.69 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$261.70 USD
+0.11 (0.04%)
Updated May 3, 2019 04:00 PM ET
After-Market: $261.69 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Stock Market News for Apr 9, 2020
by Zacks Equity Research
U.S. stocks ended sharply higher on Wednesday following investors' expectations that the U.S. economy may reopen earlier than it was previously decided.
Sanders Gives Health Insurers a Boost: Spotlight on 5 Stocks
by Tirthankar Chakraborty
Sanders' policies haven't been positive for health insurance stocks. He has favored Medicare-For-All and intended to abolish private insurance, which had cast a shadow on health insurance companies for months.
Molina Healthcare to Waive Costs Related to COVID-19 Treatment
by Zacks Equity Research
Molina Healthcare (MOH) eliminates specific 'out-of-pocket' expenses related to coronavirus treatment and undertakes several other initiatives.
Anthem to Remove Costs Related to Coronavirus Treatment
by Zacks Equity Research
Anthem's (ANTM) decision to eliminate supplementary costs related to the coronavirus treatment bodes well for its members.
Humana to Waive Expenses Related to Coronavirus Treatment
by Zacks Equity Research
Humana (HUM) to excuse members' out-of-pocket costs for COVID-19 treatment.
Anthem (ANTM) Issues Policies for Safe Coronavirus Testing
by Zacks Equity Research
Anthem (ANTM) issues updates to ease care provider protocols regarding COVID-19 testing
Humana (HUM) Extends Telehealth Services to Fight Coronavirus
by Zacks Equity Research
Humana (HUM) enhances its telehealth service facilities to combat the spread of COVID-19.
Magellan Health's Unit Enhances Services to Fight Coronavirus
by Zacks Equity Research
Magellan Health's (MGLN) behavioral and specialty healthcare segment betters its behavorial health services for those in emergency to contain the COVID-19 spread.
Want To Retire Early? Learn the Intelligent Investing Secret - March 24, 2020
by Zacks Equity Research
Accomplishing the financial cushion to retire early is a fantasy for most, but bringing that fantasy to reality is not as difficult as it sounds. If you are willing to make some serious lifestyle adjustments, it can be achievable.
The Zacks Analyst Blog Highlights: Bristol-Myers Squibb, BHP, CVS Health, T-Mobile US and Anthem
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Bristol-Myers Squibb, BHP, CVS Health, T-Mobile US and Anthem
Top Research Reports for Bristol-Myers, BHP & CVS
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Bristol-Myers Squibb (BMY), BHP Group (BHP) and CVS Health (CVS).
Teladoc Witnesses Higher Visits Due to Coronavirus Outbreak
by Zacks Equity Research
Teladoc's (TDOC) teleheath services are witnessing increase in demand due to coronavirus outbreak.
Can Telemedicine be a Market Savior on Rising Corona Scare?
by Urmimala Biswas
Here are four telemedicine stocks which have robust prospects to become attractive picks on the COVID-19 economic doldrums.
Cigna Ties Up With Houston Methodist to Provide Quality Care
by Zacks Equity Research
Cigna (CI) partners Houston Methodist to provide affordable health plans to its members.
Anthem's (ANTM) Beacon Health Buyout to Bolster Portfolio
by Zacks Equity Research
Anthem (ANTM) carries on with its acquisition spree, the latest being the purchase of Beacon Health.
Magellan Health (MGLN) Q4 Earnings Beat Estimates, Rise Y/Y
by Zacks Equity Research
Magellan Health's (MGLN) Q4 results reflect higher segment profit, partly offset by lower revenues.
Why Is Anthem (ANTM) Down 3% Since Last Earnings Report?
by Zacks Equity Research
Anthem (ANTM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Acadia Healthcare (ACHC) Q4 Earnings Top Mark, Improve Y/Y
by Zacks Equity Research
Acadia Healthcare's (ACHC) Q4 results reflect higher revenues, rise in patient days and lower expenses.
Universal Health's (UHS) Q4 Earnings Surpass, Improve Y/Y
by Zacks Equity Research
Universal Health's (UHS) Q4 results reflect higher revenues and solid segmental contributions.
Healthcare Sector to Remain Volatile in 2020 Amid Elections
by Sapna Bagaria
Disparity in the regulatory policies of presidential candidates of various parties renders volatility to the healthcare sector.
Will UnitedHealth Stock Witness Volatility til the Elections?
by Sapna Bagaria
Shares of UnitedHealth (UNH) slide on Sanders' Nevada win. Volatility is likely to continue till the elections.
Tenet Healthcare (THC) Q4 Earnings Miss Estimates, Rise Y/Y
by Zacks Equity Research
Tenet Healthcare's (THC) fourth-quarter results reflect improved performance of Ambulatory Care and Hospital segments, offset by poor performance of Conifer segment.
3 HMO 2019 Outperformers Likely to Retain Beat Streak in 2020
by Srijita Guha
HMO players are poised for growth on the back of higher revenues, membership growth, technological advancements and a solid capital position.
Community Health (CYH) Q4 Earnings Beat Estimates, Soar Y/Y
by Zacks Equity Research
Community Health's (CYH) Q4 results benefit from lower operating costs and expenses, partially offset by soft revenues.
Molina Healthcare's (MOH) Q4 Earnings Surpass, Decline Y/Y
by Zacks Equity Research
Molina Healthcare's (MOH) Q4 earnings benefit from lower expenses, partly offset by a loss of Medicaid members.